Cargando…

Can intracytoplasmic Morphologically Selected Spermatozoa Injection be Used as First Choice of Treatment for Severe Male Factor Infertility Patients?

AIM: This study was carried out to assess the outcome of the intracytoplasmic morphologically selected sperm injection (IMSI) technique compared with the previous failed intracytoplasmic sperm injection (ICSI) attempts in oligoasthenoteratozoospermia (OAT)/severe OAT (SOAT)/teratozoospermia patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Goswami, Geeta, Sharma, Meeta, Jugga, Deepika, Gouri, Devi M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892103/
https://www.ncbi.nlm.nih.gov/pubmed/29681715
http://dx.doi.org/10.4103/jhrs.JHRS_74_17
_version_ 1783313118894489600
author Goswami, Geeta
Sharma, Meeta
Jugga, Deepika
Gouri, Devi M.
author_facet Goswami, Geeta
Sharma, Meeta
Jugga, Deepika
Gouri, Devi M.
author_sort Goswami, Geeta
collection PubMed
description AIM: This study was carried out to assess the outcome of the intracytoplasmic morphologically selected sperm injection (IMSI) technique compared with the previous failed intracytoplasmic sperm injection (ICSI) attempts in oligoasthenoteratozoospermia (OAT)/severe OAT (SOAT)/teratozoospermia patients. SETTING: Institution-based, in vitro fertilization center. STUDY DESIGN: It was a nonrandomized prospective study including 57 couples who had previous one or two ICSI failures (failure due to no implantation as embryos were transferred in these cycles and had no pregnancy) due to male factor. There was no case of total fertilization failure. IMSI was carried out in these couples and the results were compared with their previously failed ICSI attempts. MATERIALS AND METHODS: Real-time selection of sperms was done using IMSI as it allows the assessment of fine nuclear morphology and vacuoles in the sperm head at a high magnification (>6000×) with differential interference contrast optics. Therefore, IMSI was applied in couples having OAT, SOAT or teratozoospermia as male factor and the results were compared with their previous failed ICSI attempts. Statistical analysis was carried out using GraphPad Prism. RESULTS AND CONCLUSION: Data analysis demonstrated significant difference in the fertilization rate between IMSI and previous ICSI attempts of these patients (30.0% vs. 52.0%; P < 0.05). The embryo quality, implantation and pregnancy rates with IMSI were also significantly higher than those of their previous ICSI cycles (32% vs. 56.4%; 30.2% vs. 68.5%; 0.0% vs. 62.4%; P < 0.05). Our conclusion is that the IMSI procedure improved embryo development and the clinical outcomes in the same infertile couples with male infertility and poor embryo development over their previous ICSI attempts and can be taken up as the treatment of choice in cases of severe male factor infertility.
format Online
Article
Text
id pubmed-5892103
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-58921032018-04-20 Can intracytoplasmic Morphologically Selected Spermatozoa Injection be Used as First Choice of Treatment for Severe Male Factor Infertility Patients? Goswami, Geeta Sharma, Meeta Jugga, Deepika Gouri, Devi M. J Hum Reprod Sci Original Article AIM: This study was carried out to assess the outcome of the intracytoplasmic morphologically selected sperm injection (IMSI) technique compared with the previous failed intracytoplasmic sperm injection (ICSI) attempts in oligoasthenoteratozoospermia (OAT)/severe OAT (SOAT)/teratozoospermia patients. SETTING: Institution-based, in vitro fertilization center. STUDY DESIGN: It was a nonrandomized prospective study including 57 couples who had previous one or two ICSI failures (failure due to no implantation as embryos were transferred in these cycles and had no pregnancy) due to male factor. There was no case of total fertilization failure. IMSI was carried out in these couples and the results were compared with their previously failed ICSI attempts. MATERIALS AND METHODS: Real-time selection of sperms was done using IMSI as it allows the assessment of fine nuclear morphology and vacuoles in the sperm head at a high magnification (>6000×) with differential interference contrast optics. Therefore, IMSI was applied in couples having OAT, SOAT or teratozoospermia as male factor and the results were compared with their previous failed ICSI attempts. Statistical analysis was carried out using GraphPad Prism. RESULTS AND CONCLUSION: Data analysis demonstrated significant difference in the fertilization rate between IMSI and previous ICSI attempts of these patients (30.0% vs. 52.0%; P < 0.05). The embryo quality, implantation and pregnancy rates with IMSI were also significantly higher than those of their previous ICSI cycles (32% vs. 56.4%; 30.2% vs. 68.5%; 0.0% vs. 62.4%; P < 0.05). Our conclusion is that the IMSI procedure improved embryo development and the clinical outcomes in the same infertile couples with male infertility and poor embryo development over their previous ICSI attempts and can be taken up as the treatment of choice in cases of severe male factor infertility. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC5892103/ /pubmed/29681715 http://dx.doi.org/10.4103/jhrs.JHRS_74_17 Text en Copyright: © 2018 Journal of Human Reproductive Sciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Goswami, Geeta
Sharma, Meeta
Jugga, Deepika
Gouri, Devi M.
Can intracytoplasmic Morphologically Selected Spermatozoa Injection be Used as First Choice of Treatment for Severe Male Factor Infertility Patients?
title Can intracytoplasmic Morphologically Selected Spermatozoa Injection be Used as First Choice of Treatment for Severe Male Factor Infertility Patients?
title_full Can intracytoplasmic Morphologically Selected Spermatozoa Injection be Used as First Choice of Treatment for Severe Male Factor Infertility Patients?
title_fullStr Can intracytoplasmic Morphologically Selected Spermatozoa Injection be Used as First Choice of Treatment for Severe Male Factor Infertility Patients?
title_full_unstemmed Can intracytoplasmic Morphologically Selected Spermatozoa Injection be Used as First Choice of Treatment for Severe Male Factor Infertility Patients?
title_short Can intracytoplasmic Morphologically Selected Spermatozoa Injection be Used as First Choice of Treatment for Severe Male Factor Infertility Patients?
title_sort can intracytoplasmic morphologically selected spermatozoa injection be used as first choice of treatment for severe male factor infertility patients?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892103/
https://www.ncbi.nlm.nih.gov/pubmed/29681715
http://dx.doi.org/10.4103/jhrs.JHRS_74_17
work_keys_str_mv AT goswamigeeta canintracytoplasmicmorphologicallyselectedspermatozoainjectionbeusedasfirstchoiceoftreatmentforseveremalefactorinfertilitypatients
AT sharmameeta canintracytoplasmicmorphologicallyselectedspermatozoainjectionbeusedasfirstchoiceoftreatmentforseveremalefactorinfertilitypatients
AT juggadeepika canintracytoplasmicmorphologicallyselectedspermatozoainjectionbeusedasfirstchoiceoftreatmentforseveremalefactorinfertilitypatients
AT gouridevim canintracytoplasmicmorphologicallyselectedspermatozoainjectionbeusedasfirstchoiceoftreatmentforseveremalefactorinfertilitypatients